HOME >> BIOLOGY >> NEWS
Researchers call for studies on role of BRCA1 mutations in chemotherapy response

Loss of BRCA1 function is associated with sensitivity to DNA-damaging chemotherapy and may also be associated with resistance to taxane-based chemotherapy. However, prospective clinical studies are needed to evaluate the role of BRCA1 in chemotherapy response, concludes a new review in the November 17 issue of the Journal of the National Cancer Institute.

BRCA1 mutations account for only 5% of breast and ovarian cancers, but loss-of-function mutations in the BRCA1 gene confer up to an 82% risk of breast cancer and up to a 54% risk of ovarian cancer. Because BRCA1 is involved in DNA repair, loss of a functioning BRCA1 gene may make a cell more vulnerable to chemotherapy agents that damage DNA, such as platinum-based compounds. In addition, BRCA1 has also been shown to be involved in the regulation of cell division, and loss of the gene has been proposed to protect a cell against spindle poisons, a group of chemotherapy agents, such as taxanes and vinca alkaloids, that disrupt cell division.

To determine whether the level of BRCA1 function in a patient could be used to predict response to chemotherapy for breast and ovarian cancers, D. Paul Harkin, B.Sc., Ph.D., and Richard D. Kennedy, M.D., Ph.D., of The Queen's University of Belfast in Northern Ireland, and colleagues reviewed published preclinical and clinical evidence. Preclinical studies included research in both animal models and cell lines. Clinical studies were all retrospective in nature, because no prospective trials have been designed to study the role of BRCA1 in chemotherapy response.

The researchers found that BRCA1 inactivation through mutation appears to confer sensitivity to DNA-damaging chemotherapeutic drugs commonly used to treat breast and ovarian cancers. However, preclinical evidence suggests that BRCA1 function is necessary for spindle poisons to work. The authors recommend that prospective studies be conducted to evaluate BRCA1 expression and chemotherapeutic res
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
16-Nov-2004


Page: 1 2

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers identify genetic mutation that may alter tumor cell proliferation
9. Researchers discover method for identifying how cancer evades the immune system
10. Researchers use adult stem cells to create soft tissue
11. Researchers find gene that spurs development of the epididymis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... 02, 2018 , ... Stem Cell Innovations (SCI), a global network of professionals ... therapy, has launched the pre-sale for their ICO with participants purchasing SCIA ... connect patients and stem cell specialists around the world. , SCI (formally ...
(Date:10/1/2018)... ... October 01, 2018 , ... NanoValent ... (ADC) like, lipid based therapeutics, today announced the National Institute of Health ... award of first year funding for two separate grants. These two grants will ...
(Date:10/1/2018)... Calif. (PRWEB) , ... October ... ... of post-translational modifications (PTMs) presents a unique challenge to proteomic studies. Often, ... within each protein. Although label-free data-independent acquisitions (DIA, or SWATH®Acquisition) have been ...
Breaking Biology News(10 mins):
(Date:10/13/2018)... , ... October 12, 2018 , ... ... society for laser education, innovation and commercialization, celebrates its 50th birthday in New ... Applications of Lasers and Electro-Optics (ICALEO) conference. , In celebration of its ...
(Date:10/5/2018)... ... October 04, 2018 , ... ... along with Duke University, announced today at IDWeek™ 2018 the positive results of ... pathogen DNA in plasma, accurately identified causative pathogens in patients with infective endocarditis ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the 2018 ... AssurEOR product line was chosen for its advancements in the production chemicals category. ... innovations in upstream oil applications that are positively impacting the industry. The winners ...
(Date:9/28/2018)... ... September 28, 2018 , ... LabRoots , the ... scientists from around the world, is excited to announce Daniel Andrade, a 22-year-old ... the winner of the LabRoots Summer 2018 Textbook Scholarship, awarding him $1,000 to ...
Breaking Biology Technology:
Cached News: